RHABDOID TUMOR OF THE KIDNEY
Clinical trials for RHABDOID TUMOR OF THE KIDNEY explained in plain language.
Never miss a new study
Get alerted when new RHABDOID TUMOR OF THE KIDNEY trials appear
Sign up with your email to follow new studies for RHABDOID TUMOR OF THE KIDNEY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with Ultra-Rare, aggressive cancers
Disease control OngoingThis study is testing whether a combination of two immunotherapy drugs (nivolumab and ipilimumab) can help control rare, aggressive cancers in children and young adults. The trial is for patients whose cancers have returned or haven't responded to standard treatments. Researchers…
Matched conditions: RHABDOID TUMOR OF THE KIDNEY
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Major trial aims to boost survival for advanced kidney cancer
Disease control OngoingThis large, late-stage trial is testing if adding a drug called cabozantinib to a standard immunotherapy regimen helps patients with advanced kidney cancer that has spread. The study will compare how long patients live and how long their cancer is controlled on the new combinatio…
Matched conditions: RHABDOID TUMOR OF THE KIDNEY
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 11, 2026 14:54 UTC